🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the efficacy (blood pressure lower...
Status
Completed
Location
Investigative Site
Start Date
2010-10
Trial ID
NCT01237223
This study evaluated the effect of early initiation of aliskiren therapy, c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-05
Trial ID
NCT00894387
This prospective multicenter, double blind study will evaluate the efficacy...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01042392
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of aliskire...
Status
Completed
Location
Novartis US
Start Date
2006-12
Trial ID
NCT00414609
The purpose of this research is to study and determine the effects of Alisk...
Status
Completed
Location
Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory
Start Date
2009-11
Trial ID
NCT01165983
The purpose of this study was to determine the effects of Aliskiren on insu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-10
Trial ID
NCT00417170
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
This study was specifically designed to provide additional information on t...
Status
Completed
Location
Investigative Site
Start Date
2009-03
Trial ID
NCT00865020
Treatments Being Tested
Evaluate the efficacy (blood pressure lowering effect) and safety of aliski...
Status
Completed
Location
Investigative Site
Start Date
2008-09
Trial ID
NCT00739973
To compare the efficacy and safety of aliskiren in combination with losarta...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-10
Trial ID
NCT00219141
Treatments Being Tested